Uptake of hepatitis C cures tanks

HomeThe Hep-VineUptake of hepatitis C cures tanks

Hundreds of thousands of Australians with hepatitis C are failing to access new curative drugs, despite the Government subsidising them at huge cost to the taxpayer.

The trend means the Government is at risk of missing its target to eradicate hepatitis C and of spending far more than necessary on the treatments.

Fewer than half as many people are accessing the direct acting antivirals as they were immediately after they were first listed on the Pharmaceutical Benefits Scheme in March 2016.



Post a comment